Theresa Asen
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
Journal: Frontiers in immunology
Published: November 18, 2023
Vector-Mediated Delivery of Human Major Histocompatibility Complex-I into Hepatocytes Enables Investigation of T Cell Receptor-Redirected Hepatitis B Virus-Specific T Cells in Mice, and in Macaque Cell Cultures.
Journal: Human gene therapy
Published: September 25, 2023
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection.
Journal: Vaccines
Published: June 22, 2021
T cell receptor grafting allows virological control of Hepatitis B virus infection.
Journal: The Journal of clinical investigation
Published: May 01, 2019
Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 29, 2018
Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Journal: Journal of hepatology
Published: February 12, 2018
Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
Journal: PloS one
Published: May 05, 2017
Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice.
Journal: Hepatology (Baltimore, Md.)
Published: November 05, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026